Chief Financial Officer Mike Marks provided same-facility volume details for the fourth quarter of 2025 compared with the fourth quarter of 2024:For the fourth quarter, Hazen said revenue increased 6.7% year over year, and the company improved margins both sequentially and year over year with “disciplined expense management.” He added that net income attributable to HCA Healthcare rose nearly 31% in the quarter, while diluted earnings per share as adjusted increased 29% and adjusted EBITDA increased about 1 ...

- Sparta and Warrenton Nursing Facilities and Related Property Sold for $13.18 Million -DENVER, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced its wholly-owned subsidiaries, Providence HR, LLC and Atl/Warr, LLC (each a “Seller”), have completed the sale of two properties located in Georgia, including the skilled nursing facilities known as Providence of Sparta Health & Rehab (collectively, “the Sparta Facility”), located in Sparta, Georgia, as wel ...

Core Insights - The article discusses the preferences of investors regarding dividend income, highlighting the trade-off between higher yields from individual companies and the stability of instruments like CDs and ETFs [1] Group 1: Company Profiles - CBL & Associates Properties, Inc. (CBL) is a self-managed REIT focused on regional shopping malls and commercial properties, with a forward dividend yield of 4.5% and a 5-year CAGR of 14.76% [2][4] - Universal Health Realty Income Trust (UHT) offers a higher dividend yield of 7.5% and focuses on healthcare facilities, but has a lower 5-year dividend CAGR of 1.39% [7][12] - Oil-Dri Corporation of America (ODC) is not a REIT and offers a dividend yield of 1.34% with a 5-year CAGR of around 5%, while its stock has appreciated over 200% in the past 5 years [13][15] Group 2: Dividend Characteristics - CBL is legally required to pay out at least 90% of its taxable income as dividends, reducing the risk of abrupt changes in capital allocation strategies [5] - UHT's focus on the healthcare sector may attract investors seeking stability, but its lower growth rate may appeal more to short-term income investors [12] - ODC's dividend payout ratio is 20%, indicating a healthy cushion for funding dividends alongside other needs, though it carries a risk of dividend cuts due to its non-REIT status [16][17]

InnovAge (NasdaqGS:INNV) FY Conference January 12, 2026 12:45 PM ET Company ParticipantsBen Adams - CFOPatrick Blair - CEOBen Rossi - Head of European Medtech & ServicesBen RossiAll right. Thank you so much. First and foremost, thank you for all of us joining us in here in person in the room, and for those who are joining us via webcast, my name is Ben Rossi, and I'm the Healthcare Facilities Analyst here at J.P. Morgan. We're excited to be welcoming InnovAge back to the stage this morning. With us here tod ...

Market Overview - The S&P 500 has increased nearly 18% in 2025, marking the potential for a third consecutive year of double-digit gains for the broader US market [1] - Wall Street anticipates continued profit growth, with S&P 500 earnings expected to rise by approximately 15.5% in 2026, up from 13.2% in 2025 and 12.1% in 2024 [2] - Goldman Sachs forecasts a 2.6% growth in US GDP for 2026, slightly above consensus, indicating a supportive environment for stock prices [3] Dividend Stocks Performance - The Dividend Aristocrat index, tracking companies with at least 25 consecutive years of dividend growth, has risen over 6% this year, maintaining investor interest in dividend stocks for income and consistency [4] - A review of companies with the strongest returns in 2025 led to the selection of 20 dividend-paying stocks based on year-to-date performance, not on dividend size [6] Company Highlights C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - YTD return as of December 30 is 58.08% with a dividend yield of 1.56% [9] - The company reported a profit beat in Q3 2025, attributed to its use of AI for operational efficiency, which has helped streamline logistics processes [10][12] - Revenue for the North American Surface Transportation segment increased by 1.1%, despite a challenging backdrop in US freight volumes [11] RTX Corporation (NYSE:RTX) - YTD return as of December 30 is 58.84% with a dividend yield of 1.48% [13] - The company secured a $1.6 billion sustainment contract for F135 engines and raised its full-year adjusted earnings outlook to $6.10 to $6.20, up from $5.80 to $5.95 [15][16] - RTX's ability to manage tariff impacts positively reflects on its business outlook, with a forecasted revenue increase to $86.5 billion to $87 billion [17] HCA Healthcare, Inc. (NYSE:HCA) - YTD return as of December 30 is 58.85% with a dividend yield of 0.61% [18] - The company reported a 2.1% year-over-year increase in same-facility admissions and a 6.6% increase in revenue per equivalent admission [20] - HCA aims to increase its market share from 27% in 2022 to 29% by 2030, supported by an aging population and ongoing investments in technology [21][22]

Summary of Healthcare Services Conference Call Industry Overview - The conference call focused on the **Healthcare Services** industry, particularly the **Managed Care** sector and its outlook for 2026, highlighting potential margin improvements and policy clarity as positive factors for growth [4][10][11]. Key Points and Arguments Managed Care - **Earnings Recovery**: Most Managed Care Organizations (MCOs) are expected to reach trough earnings in 2026, with potential upward revisions thereafter. Medicare Advantage (MA) is anticipated to drive margin upside, while skepticism remains around Medicaid and ACA Exchanges until MCOs demonstrate margin improvements [5][12]. - **Enrollment Trends**: MCOs are targeting enrollment declines to improve margins, with companies like CVS, ELV, and UNH focusing on this strategy. Conversely, HUM is positioned for membership growth [12][52]. - **Regulatory Environment**: The 2026 midterms are expected to create gridlock, reducing the likelihood of major policy changes outside of CMS rulemaking, which could stabilize the operating environment for MCOs [5][12]. Pharmaceutical Distributors - **Strong Fundamentals**: The current strength in results for pharmaceutical distributors is attributed to stable generic pricing, MSO growth, and a robust specialty pipeline. Companies like McKesson (MCK) and Cencora (COR) are favored due to their strong specialty businesses [9][16]. - **M&A Activity**: Distributors led M&A activity in 2025, with expectations for continued integration and organic investment in MSO capabilities in 2026 [25]. Labs and Healthcare Facilities - **Demand Trends**: Labs are expected to see steady demand trends with a healthy backdrop in diagnostics. Regulatory uncertainties may impact pricing and mix development, but overall operating conditions are stable [9][12]. - **Facility Performance**: Healthcare facilities are positioned to benefit from favorable utilization trends, although policy uncertainty remains a concern for future earnings growth [12][16]. Additional Insights - **Investment Picks**: Top investment picks include UnitedHealth (UNH) and CVS Health (CVS) for their cleaner stories, while Cigna (CI) is seen as attractive but with more complexities [5][14][17]. - **Margin Pressures**: Medicaid remains a challenge, with companies like ELV and UNH guiding for margin pressure in 2026. Investment income is also expected to be a headwind for managed care [5][12]. - **Market Dynamics**: The ACA Exchanges are viewed as a swing factor for MCOs, with a wide range of outcomes expected due to potential shifts in market morbidity [12][43]. Conclusion The healthcare services industry is navigating a complex landscape with potential for margin recovery and growth driven by Medicare Advantage, while facing challenges in Medicaid and ACA Exchanges. The focus on regulatory clarity and strategic M&A activity will be crucial for companies as they prepare for 2026 and beyond.

Summary of the 2026 Hospital Outlook Survey Industry Overview - The survey focuses on the US healthcare industry, specifically the hospital sector, and provides insights into capital expenditures, utilization trends, and the impact of macroeconomic factors on hospital operations [1][2]. Key Insights Utilization Trends - **Utilization Growth Expectations**: 52% of hospital executives anticipate utilization growth in 2026 to be above 2025 levels, a decrease from 55% in the previous year [7][19]. - **Outpatient vs. Inpatient**: 56% expect outpatient utilization growth to exceed 2025 levels, while 41% expect inpatient utilization growth to increase, up from 34% last year [11][19]. - **Elective Procedures**: 54% expect elective procedures to grow above or in line with 2025 levels, down from 64% last year [16][19]. Capital Expenditures (CapEx) - **CapEx Growth**: Hospital capital spending is projected to increase by 4.1% in 2026, consistent with the 4.0% growth reported in 2025 [7][45]. - **Investment Priorities**: Hospitals are likely to increase spending on bedside patient monitoring, bedside pumps, and operating room (OR) suite equipment [16][45]. - **Impact of OBBBA**: The One Big Beautiful Bill Act (OBBBA) may lead to conservative spending due to anticipated reimbursement pressures [49][46]. Robotics and Technology - **Robotic Systems**: 96% of hospitals currently utilize surgical robotic systems, with Intuitive Surgical maintaining a leading position in soft-tissue robotics [90][91]. - **Orthopedic Robotics Demand**: 49% of respondents expect to purchase orthopedic robotic systems, with Stryker's MAKO being the most favored option [7][8]. - **IT Investments**: Hospitals are prioritizing IT investments, particularly in AI (66% expect to increase spending) and cybersecurity (65%) [80][81]. Value-Based Care (VBC) - **Revenue Tied to VBC**: The average revenue tied to VBC arrangements is approximately 19%, down from 22% last year, although interest in establishing VBC partnerships has increased [34][35]. Challenges and Concerns - **Reimbursement Pressure**: 34% of executives cite reimbursement pressure as the biggest challenge for hospitals in the coming year, an increase from 25% last year [58][59]. - **Labor Costs**: Labor cost inflation remains a significant concern, with 18% of respondents identifying it as a major challenge [58][59]. Future Outlook - **Purchasing Intentions**: Despite economic uncertainties, over 70% of hospitals plan to consider purchasing new equipment across various categories in the next two years [62][64]. - **Investment in ASCs**: 57% of respondents expect to increase investments in Ambulatory Surgery Centers (ASCs) over the next year, reflecting a shift towards outpatient care [18][19]. Additional Insights - **AI Utilization**: Hospitals are increasingly leveraging AI for tasks such as medical record analysis (56%) and clinical imaging analysis (52%), with larger hospitals showing a higher propensity to adopt these technologies [81][88]. - **Market Dynamics**: The survey indicates a stable payor mix for 2026, with commercial insurers and Medicare making up approximately 70% of the mix [12][27]. This comprehensive survey provides a detailed outlook on the hospital sector, highlighting trends in utilization, capital spending, and the evolving landscape of healthcare technology and reimbursement challenges.

Group 1: HCA Healthcare - HCA Healthcare has seen significant financial growth, with Q3 revenue increasing by 9.6% year over year to $19.2 billion and net income rising by 29.4% to $1.6 billion [3] - The company benefits from rising demand for medical services, with same-facility admissions up by 2.1% and same-facility revenue per equivalent admission increasing by 6.6% to $18,390 [3] - HCA Healthcare's market share has grown from 24% in 2012 to 27% in 2022, with a goal to reach 29% by 2030, supported by a diversified network and technology investments [6][7] Group 2: CVS Health - CVS Health is undergoing a multiyear plan to cut costs and is scaling back its Medicare Advantage offerings to focus on profitable growth [8][9] - The company has a strong ecosystem that includes pharmacy, insurance, and primary care services, and has expanded through acquisitions and new subsidiaries [11] - CVS Health is well-positioned to benefit from an aging population and increasing demand for prescription drugs, making its stock attractive for long-term holding [13]

Market Performance - Major U.S. equities indexes showed mixed results, with the Dow increasing by 0.4% and the S&P 500 rising by 0.1%, while the tech-heavy Nasdaq decreased by 0.2% [1] Company Highlights - Microchip Technology was the best-performing stock in the S&P 500, with shares climbing nearly 10% after the company raised its guidance due to strong bookings and an improved backlog [1] - American Eagle Outfitters saw a 15% increase in shares after reporting better-than-expected earnings, attributed to successful advertising campaigns featuring Sydney Sweeney and Travis Kelce [1] - Dollar Tree's shares rose approximately 3% as the discount retailer reported quarterly profits exceeding analysts' estimates and raised its outlook, benefiting from increased consumer demand for value [1] - Alexandria Real Estate Equities was the worst-performing stock in the S&P 500, with shares down 7% following weak guidance and a dividend cut [1] - Acadia Healthcare's shares fell 13% after the company warned of higher-than-expected liability costs [1] Industry Trends - Oil and gold futures advanced, indicating a positive trend in commodity markets [1] - The yield on the 10-year Treasury note decreased to 4.07%, reflecting changes in bond market dynamics [1] - The U.S. dollar weakened against the euro, pound, and yen, suggesting shifts in currency markets [1] - Prices for most major cryptocurrencies increased, indicating a positive trend in the digital asset space [1]

Core Insights - The Ensign Group reported strong operational execution in Q3, with revenue growth driven by higher patient volumes and improved clinical outcomes [1] - Management highlighted the importance of occupancy and skilled patient mix, attributing success to their decentralized, locally led model [1] - CEO Barry Port emphasized clinical performance as a key differentiator, with same-store facilities outperforming peers in government surveys and achieving record occupancy [1] Financial Performance - Revenue reached $1.30 billion, exceeding analyst estimates of $1.28 billion, representing a 19.8% year-on-year growth [6] - EPS (GAAP) was $1.42, missing analyst expectations of $1.49 by 4.9% [6] - Adjusted EBITDA was $151.1 million, beating analyst estimates of $147.1 million, with an 11.7% margin [6] - The company raised its full-year revenue guidance to $5.06 billion, a 1.1% increase from the previous guidance of $5.01 billion [6] - Full-year EPS (GAAP) guidance is $6.51, exceeding analyst estimates by 12.1% [6] - Operating margin remained stable at 7.4%, consistent with the same quarter last year [6] - Sales volumes increased by 15.1% year-on-year, compared to 9.9% in the same quarter last year [6] - Market capitalization stands at $10.35 billion [6] Strategic Insights - There is significant potential for skilled mix growth in mature facilities, with only 31.7% of same-store days currently skilled [6] - Organic growth remains a major focus for the company [6] - Managed care contracting in new markets, such as Alabama, is a gradual process that requires time to establish relationships [6] - Acquisition timing is primarily influenced by seller readiness, with a focus on maintaining discipline in pricing despite competitive pressures [6] - The company is expanding behavioral health services, with new units being added in Arizona and California to meet increased demand [6] - Ensign's facilities are positioned as high-quality, lower-cost alternatives, enabling gradual market share gains over time [6]